Skip to main content

Table 2 Means and standard deviations of biohumoral characteristics of subjects at baseline, at 1 month, 6 months, 12 months and follow-up. Values are expressed as Mean (SD)

From: Job performance in chronic hepatitis C virus patients treated with pegylated interferon-α2b plus ribavirin: an observational study

 

Before Treatment

After 1 month

After 6 months

After 12 months

Follow-up

AST (IU/L)

184.4 ± 37.1

180.2 ± 35.6

96.4 ± 37.4**

68.2 ± 24.9**

65.4 ± 22.1**

ALT(IU/L)

196.8 ± 36.4

185.4 ± 36.2

104.4 ± 38.1**

69.1 ± 20.6**

71.4 ± 16.1**

BILIRUBIN (mmol/L)

10.2 ± 6.8

10.2 ± 6.4

10.3 ± 6.9

10.1 ± 6.4

10.5 ± 6.1

ALBUMIN (g/dL)

4.0 ± 0.7

4.0 ± 0.6

4.1 ± 0.7

4.0 ± 0.9

4.2 ± 0.5

VIREMIA (106 IU/mL)

5.44 ± 2.20

5.22 ± 2.19

3.9 ± 2.8**

2.87 ± 2.0**

2.9 ± 1.8**

HAI

10.1 ± 3.6

-

-

7.8 ± 2.9**

-

  1. Comparison between baseline and after the treatment *p < 0.05 **p < 0.01